NeoGenomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.

CEO

Anthony P. Zook

CEOAnthony P. Zook

Employees

2,200

Employees2,200

Headquarters

Fort Myers, Florida

HeadquartersFort Myers, Florida

Founded

1998

Founded1998

Employees

2,200

Employees2,200

NEO Key Statistics

Market cap

1.05B

Market cap1.05B

Price-Earnings ratio

-9.76

Price-Earnings ratio-9.76

Dividend yield

—

Dividend yield—

Average volume

3.69M

Average volume3.69M

High today

$8.20

High today$8.20

Low today

$7.60

Low today$7.60

Open price

$8.02

Open price$8.02

Volume

3.64M

Volume3.64M

52 Week high

$19.12

52 Week high$19.12

52 Week low

$4.72

52 Week low$4.72

NEO News

Simply Wall St 11h

Exact Sciences’ Cancerguard™ Launch Could Be a Game Changer for NeoGenomics

Earlier this month, Exact Sciences introduced Cancerguard™, a multi-cancer early detection blood test, entering direct competition with NeoGenomics in the oncol...

Analyst ratings

53%

of 15 ratings

Buy

40%

Hold

53.3%

Sell

6.7%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.